Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 9Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Oropharyngeal Neoplasms 7Mouth Neoplasms 7Laryngeal Neoplasms 7Carcinoma 6Hypopharyngeal Neoplasms 5Urinary Bladder Neoplasms 4Pancreatic Neoplasms 3Nasopharyngeal Carcinoma 3Vulvar Neoplasms 2Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Paranasal Sinus Neoplasms 2Lymphoid Interstitial Pneumonia 2Cholangiocarcinoma 2Anus Neoplasms 2Adenocarcinoma of Lung 2Urethral Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Stomatitis 1Stomach Neoplasms 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Sinonasal undifferentiated carcinoma 1Sinonasal Squamous Cell Carcinoma 1Sertoli-Leydig Cell Tumor 1

Interventions

Taxes 3Paclitaxel 3Carboplatin 3Immunoglobulin G 2Disulfides 2Bevacizumab 2trastuzumab biosimilar HLX02 1temsirolimus 1nintedanib 1linrodostat 1ixabepilone 1cediranib 1brivanib 1Trastuzumab 1Sunitinib 1Sirolimus 1Radiotherapy, Intensity-Modulated 1Platinum 1PF-05280014 1Ontruzant 1Ogivri 1Nivolumab 1Medroxyprogesterone Acetate 1Medroxyprogesterone 1MK 2206 1Gemcitabine 1Epothilones 1Cisplatin 1Brachytherapy 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Endometrial Adenocarcinoma × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT01005329 2018-03-15

Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer

National Cancer Institute (NCI)

Phase 2 Completed
34 enrolled 10 charts
Gynecologic

Endometrial Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡